Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06256939 · ClinicalTrials.gov registry record · NA

Therapy BRIDGE (Bringing Real-Time Instruction Via Developmental and Gestationally-appropriate Education/Coaching) Program: A Pilot Study

A NA study of Intraventricular Hemorrhage, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06256939: Completed NA study of Intraventricular Hemorrhage, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT06256939 is a NA study of Intraventricular Hemorrhage that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 15 participants, below the 1,212-participant average among 11 other Intraventricular Hemorrhage trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06256939, a NA study of Intraventricular Hemorrhage, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot study is to develop a novel caregiver education and coaching intervention for infants with intraventricular hemorrhage (IVH) and their caregivers during the NICU to home transition. The main questions it aims to answer are: 1. Development of a novel caregiver education and coaching intervention focused on infant development and caregiver needs to "bridge the gap" during the NICU to home transition 2. Pilot test the feasibility, acceptability, and efficacy of this program for infants with intraventricular hemorrhage (IVH) and their caregivers.

Primary Outcome

A client-centered outcome measure that helps identify and prioritize barriers that limit participation in meaningful activities (e.g., play, feeding, sleep, etc.). The COPM is a valid, responsive, and reliable scale that allows researchers to determine clinically significant changes in participants' performance and satisfaction. Participants will rate items on a scale of 1-10 with the average performance/satisfaction scores calculated (higher correlates with higher satisfaction/performance).

Interventions

  • OTHER Therapy BRIDGE Program

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-11-16
Est. Completion 2024-09-30
Phase NA

What the finished NCT06256939 record still lists

NCT06256939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,212-participant average among 11 other Intraventricular Hemorrhage trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Intraventricular Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Therapy BRIDGE Program is the first listed.

NCT06256939 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06256939 about?

NCT06256939 is a clinical study titled "Therapy BRIDGE (Bringing Real-Time Instruction Via Developmental and Gestationally-appropriate Education/Coaching) Program: A Pilot Study". The goal of this pilot study is to develop a novel caregiver education and coaching intervention for infants with intraventricular hemorrhage (IVH) and their caregivers during the NICU to home transition. The main questions it aims to answer are: 1. Development of a novel caregiver education and co...

What is the current status of trial NCT06256939?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-11-16. Estimated completion is 2024-09-30.

What conditions does trial NCT06256939 study?

This clinical trial studies the following conditions: Intraventricular Hemorrhage.

What interventions are being tested in trial NCT06256939?

The interventions under investigation include: Therapy BRIDGE Program (OTHER).

Who is sponsoring clinical trial NCT06256939?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06256939 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intraventricular Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06256939's enrollment target sits among peer trials

15 12th of 11 the lowest of 11 other Intraventricular Hemorrhage trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intraventricular Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06256939, the US trial registry maintained by the National Library of Medicine. NCT06256939 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.